MCM
TWST icon

Manchester Capital Management’s Twist Bioscience TWST Stock Holding History

Manchester Capital Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-50
Closed -$7K – 789
2020
Q4 		$7K Sell
50
-50
-50% -$5.55K ﹤0.01% 509
2020
Q3 		$8K Buy
+100
New +$6.23K ﹤0.01% 440

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Manchester Capital Management's TWST Position: Q1 2021 in Review

Manchester Capital Management sold out of Twist Bioscience (TWST) in Q1 2021, closing a stake of 50 shares — an estimated $7K sold.

Manchester Capital Management first reported a position in TWST in Q3 2020 and held it in 2 quarters. The position peaked at $8K in Q3 2020. 239 funds tracked by Wall St. Rank hold TWST as of Q1 2021.

  • Manchester Capital Management reported no remaining Twist Bioscience position as of Q1 2021 after selling out during the quarter.
  • Manchester Capital Management sold 50 Twist Bioscience shares in Q1 2021, an estimated $7K.
  • Manchester Capital Management first reported a position in Twist Bioscience in Q3 2020 and held it in 2 quarters.
  • Manchester Capital Management's Twist Bioscience position peaked at $8K in Q3 2020.
  • 239 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2021.

Based on Manchester Capital Management's 13F filing for Q1 2021, filed 13 May 2021.